Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis

Michael J. Wagner*, Seth M. Pollack, Lee D. Cranmer, Matthew J. Thompson, Shannon Maxwell, Stephanie Wright, Ali R. Khaki, Margaret M. Madeleine, Petros Grivas, Nicole M. Kuderer, Gary H. Lyman, Elizabeth T. Loggers

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24–69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6–41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20–62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed.

Original languageEnglish (US)
Pages (from-to)315-320
Number of pages6
JournalCancer Investigation
Volume39
Issue number4
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • COVID-19
  • Sarcoma
  • cohort Study

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis'. Together they form a unique fingerprint.

Cite this